Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy can cause constipation, though it is not the most common gut side effect. Semaglutide slows the movement of food through the digestive tract, and for some people that means bowel habits become less frequent or harder to manage, particularly in the first weeks of treatment or after a dose increase. It is a Prescription-Only Medicine, and a clinician will discuss your individual risk profile — including this — before any prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing gastric emptying, food leaves the stomach more gradually, which reduces appetite and blunts post-meal blood-sugar spikes. That same mechanism extends further along the gut for some people, reducing the frequency of bowel movements. The broader side-effect picture for Wegovy is led by nausea and diarrhoea, but constipation sits firmly in the list too, as the NHS semaglutide patient page confirms.
The timing matters. Constipation tends to be most noticeable in the first few weeks after starting or after each dose step, and you can read more about whether Wegovy gives you constipation and why it happens in more detail. Once your body adjusts to a given dose, gut motility often finds a new rhythm. Not everyone experiences it; individual response varies considerably, and some people find their digestion settles quickly while others manage it for longer stretches.
If you are considering Wegovy and have a history of constipation or irritable bowel syndrome, that is worth flagging during your consultation, a prescriber needs the full picture before deciding whether treatment is appropriate for you.
Fluid intake is the first lever. Reduced appetite on Wegovy sometimes means people eat and drink less without realising, and mild dehydration makes constipation considerably worse. Aiming to drink enough water across the day (not in one go) is straightforward and often effective.
Fibre is the second. Soluble fibre from oats, pulses and vegetables adds bulk to stool without the irritation that very high insoluble fibre can cause when the gut is already sluggish. If you are eating smaller portions on treatment (which is common), fibre quality in what you do eat becomes more important, not less.
Gentle movement also helps. A short walk after meals is not glamorous advice, but it genuinely supports gut motility. For personalised guidance on diet while on treatment, the weight-loss treatment overview at nume explains how lifestyle support fits alongside the medicine.
Laxatives are sometimes needed in the short term. Which type is appropriate is a conversation for your prescriber or pharmacist, not a decision to make from a pharmacy shelf without clinical input, particularly if you are also taking other medicines.
Most constipation on Wegovy is uncomfortable but not dangerous, though our dedicated page on Wegovy drug side effects sets out the full range of what to watch for. There are situations, however, where you should seek medical help rather than wait it out.
Severe, persistent abdominal pain (especially pain that spreads towards the back) is not typical constipation. The MHRA highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 medicines in a Drug Safety Update published in January 2026, and that kind of pain warrants prompt medical assessment. Vomiting alongside inability to pass stool, blood in the stool, or abdominal pain that does not ease with normal bowel movement are all reasons to contact a GP or NHS 111 the same day.
If you are unsure whether what you are experiencing is within the expected range, our support team is available seven days a week and can advise whether to escalate to your GP or prescriber. You can also report any suspected side effect directly to the MHRA via the Yellow Card scheme, the scheme exists precisely for this.
For anything urgent, call 999 or go to A&E. This page does not replace clinical advice.
Knowing that constipation is possible is a reasonable thing to factor in before you start treatment, but it rarely changes the clinical calculus by itself. For most people the metabolic benefits of sustained weight loss outweigh a manageable gut side effect, especially when the side effect is front-loaded in the early weeks. If you want a closer look at the evidence, our page on whether Wegovy makes you constipated goes into the clinical detail.
What changes the picture: if constipation is already a significant daily issue for you, or if you have a bowel condition that could be complicated by slower transit, your prescriber needs to know. Our guidance for anyone who finds themselves constipated on Wegovy covers practical steps and when to seek further help. The decision about whether Wegovy is right for you sits with a clinician who can weigh your specific history, not a checklist on a website.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real person reviewing your answers on the day you submit. The full Wegovy treatment information at nume covers what that consultation involves, and our FAQs page addresses the questions people most commonly raise before starting. If you are ready to take the next step, you can check your eligibility with a free consultation. Side effects, including this one, are part of that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.